206 related articles for article (PubMed ID: 32277134)
1. Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia.
Zeng Z; Peng CZ; Liu JB; Li YW; He HF; Hu QH; Lin B; Shen XG
Sci Rep; 2020 Apr; 10(1):6206. PubMed ID: 32277134
[TBL] [Abstract][Full Text] [Related]
2. Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics.
Ha EJ; Baek JH; Baek SM
Korean J Radiol; 2020 Dec; 21(12):1383-1392. PubMed ID: 32767864
[TBL] [Abstract][Full Text] [Related]
3. Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism.
Qin X; Wang B; Li B; Lin C; Liu X; Xie X
Ren Fail; 2021 Dec; 43(1):445-451. PubMed ID: 33663332
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience.
Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Li D; Yue W; Peng C; Xu HX
Endocrine; 2024 Mar; 83(3):681-690. PubMed ID: 37725290
[TBL] [Abstract][Full Text] [Related]
5. Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.
Wei Y; Peng L; Li Y; Zhao ZL; Yu MA
Korean J Radiol; 2020 May; 21(5):572-581. PubMed ID: 32323502
[TBL] [Abstract][Full Text] [Related]
6. US-guided percutaneous radiofrequency ablation of secondary hyperparathyroidism as a bridge to renal transplantation.
Yue W; Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Xu D; Peng C
Int J Hyperthermia; 2023; 40(1):2223370. PubMed ID: 37344379
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-Guided Radiofrequency Ablation for the Treatment of Primary Hyperparathyroidism: An Efficacy and Safety Study.
Li X; Tufano RP; Russell JO; Yan L; Xiao J; Li Y; Zhang M; Luo Y
Endocr Pract; 2021 Dec; 27(12):1205-1211. PubMed ID: 34311118
[TBL] [Abstract][Full Text] [Related]
8. Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease.
Lin LP; Lin M; Wu SS; Liu WH; Zhang L; Ruan YP; Gao MZ; Hong FY
Ren Fail; 2023 Dec; 45(1):2215334. PubMed ID: 37345712
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease.
Peng C; Zhang Z; Liu J; Chen H; Tu X; Hu R; Ni J; Weng N; Pang H; Xue Z
Head Neck; 2017 Mar; 39(3):564-571. PubMed ID: 28032671
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study.
Qiu X; Gao M; Zhang D; Ji F
Sci Rep; 2023 Oct; 13(1):16949. PubMed ID: 37805586
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study.
Chen CC; Chen HL; Chiang PL; Luo SD; Chang YH; Chen WC; Wang CK; Lin AN; Chen YS; Chi SY; Lin WC
Int J Hyperthermia; 2022; 39(1):907-917. PubMed ID: 35848429
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study.
Ren M; Zheng D; Wu J; Liu Y; Peng C; Shen W; Lin B
Sci Rep; 2022 Jun; 12(1):10289. PubMed ID: 35717444
[TBL] [Abstract][Full Text] [Related]
13. Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis.
Xu W; Li S; Cheng F; Gong L; Tang W; Lu J; Li Y; Wang Z
Int Urol Nephrol; 2023 Sep; 55(9):2237-2247. PubMed ID: 36892812
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study.
Li X; Wei Y; Shao H; Peng L; An C; Yu MA
Int J Hyperthermia; 2019; 36(1):647-653. PubMed ID: 31305184
[No Abstract] [Full Text] [Related]
15. US-guided Microwave Ablation of Hyperplastic Parathyroid Glands: Safety and Efficacy in Patients with End-Stage Renal Disease-A Pilot Study.
Zhuo L; Peng LL; Zhang YM; Xu ZH; Zou GM; Wang X; Li WG; Lu MD; Yu MA
Radiology; 2017 Feb; 282(2):576-584. PubMed ID: 27552557
[TBL] [Abstract][Full Text] [Related]
16. Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients.
Jäger MD; Serttas M; Beneke J; Müller JA; Schrem H; Kaltenborn A; Ramackers W; Ringe BP; Gwiasda J; Tränkenschuh W; Klempnauer J; Scheumann GFW
PLoS One; 2017; 12(10):e0186093. PubMed ID: 29040300
[TBL] [Abstract][Full Text] [Related]
17. A Nomogram to Predict Hungry Bone Syndrome After Parathyroidectomy in Patients With Secondary Hyperparathyroidism.
Wang M; Chen B; Zou X; Wei T; Gong R; Zhu J; Li Z
J Surg Res; 2020 Nov; 255():33-41. PubMed ID: 32540578
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-Guided Radiofrequency Ablation in Tertiary Hyperparathyroidism: A Prospective Study.
Deng E; Jiang T; Chai H; Weng N; He H; Zhang Z; Peng C; Yue W; Xu H
Korean J Radiol; 2024 Mar; 25(3):289-300. PubMed ID: 38413113
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid glands: combination of sestamibi-(99m)Tc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands.
Kasai ET; da Silva JW; Mandarim de Lacerda CA; Boasquevisque E
Rev Esp Med Nucl; 2008; 27(1):8-12. PubMed ID: 18208776
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation.
Peng CZ; Chai HH; Zhang ZX; Hu QH; Zeng Z; Cui AL; Pang HS; Ruan LT
Int J Hyperthermia; 2022; 39(1):490-496. PubMed ID: 35285391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
